June 15, 2022 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers duri

June 15, 2022 — Current guidelines used to plan salvage radiation treatments in patients with local recurrence of prostate cancer should be updated to take into consideration information derived from novel imaging modalities, such as PSMA PET, according to research presented at the Society of Nuclear Medicine and

June 14, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), incorporating AI support into clinical practice can reduce repetitive tasks, saving approximately one hour of chest CT interpretation time in a radiologist’s typical workday.

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and subsequently decrease radiation exposure to the patient.

June 14, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.

June 14, 2022 — Munir Ghesani, MD, FACNM, FACR, chief of nuclear medicine and molecular imaging at Mount Sinai Health System and associate professor of radiology at Mount Sinai Hospital in New York, NY, has been named as president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2022 Annual Meeting, held June 11-14.

June 13, 2022 — As demand for minimally invasive surgery continues to grow, GE Healthcare is committed to helping clinicians use image guidance technologies to their full potential by removing barriers in order to provide quality care to patients for better clinical and operational outcomes.

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro.specta, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with advanced CT and SPECT imaging technologies.

June 13, 2022 — SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences industry that specializes in radiopharmaceuticals, today announced that it will showcas

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now